Mr. Noah J. Kroloff is a Partner at NGN Capital. He has almost 20 years experience in healthcare sector including senior operating roles. Prior to this, Mr. Kroloff was an Executive Officer at i-STAT Corporation, where he served as a Vice President for International Sales and Marketing and Corporate Development. Mr. Kroloff was actively involved in the sale of i-STAT to Abbott Laboratories for approximately $450 million. He also led the creation of a global alliance with Abbott and a $61 million alliance with Hewlett-Packard Medical Products Group, created i-STAT’s international distribution network, and led licensing and deal-making activities. Prior to i-STAT, Mr. Kroloff was an Engagement Manager at McKinsey & Co., where he advised leading pharmaceutical and diagnostic companies on research and development management, portfolio strategy, and alliance formation. Mr. Kroloff has also performed significant work for Merck and Rosetta Genomics. Prior to his work in healthcare, he was a Senior Analyst at Fannie Mae and Associate at Industrial Economics, Inc. He has been a Director of Benechill, Inc. since 2008. He serves as a Director at Coagulation Sciences LLC, and Valtech Cardio and Cerapedics, Inc. He has also served as a Director of McKinsey’s Alumni Advisory Council and the Technion NY Metro. Mr. Kroloff received an M.B.A. from the MIT Sloan School, where he co-founded and served as a judge of the MIT $100K Entrepreneurship Competition and a B.A. in General Science from Brandeis University.

Health care, Genomics